G01N 2440/00
Post-translational modifications [ptms] in chemical analysis of biological material
Official title: Post-translational modifications [PTMs] in chemical analysis of biological material
G01N2440/00 (Post-translational modifications [ptms] in chemical analysis of biological material) appears on 555 US grants and 1,246 published applications in this corpus.
Search patents in G01N- Granted patents
- 555
- Published applications
- 1,246
- Assignees
- 649
- Inventors
- 2,555
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 6 |
| 2006 | 0 | 4 |
| 2007 | 0 | 1 |
| 2008 | 1 | 5 |
| 2009 | 4 | 5 |
| 2010 | 0 | 13 |
| 2011 | 2 | 23 |
| 2012 | 8 | 32 |
| 2013 | 17 | 46 |
| 2014 | 19 | 75 |
| 2015 | 33 | 106 |
| 2016 | 41 | 121 |
| 2017 | 51 | 96 |
| 2018 | 59 | 76 |
| 2019 | 40 | 74 |
| 2020 | 55 | 70 |
| 2021 | 44 | 79 |
| 2022 | 37 | 83 |
| 2023 | 34 | 85 |
| 2024 | 35 | 88 |
| 2025 | 49 | 88 |
| 2026 | 25 | 67 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2440/14PhosphorylationIndexing code200
- G01N 2440/38Addition of carbohydratesIndexing code158
- G01N 2440/36Addition of addition of other proteins or peptidesIndexing code44
- G01N 2440/10AcylationIndexing code33
- G01N 2440/12AlkylationIndexing code31
- G01N 2440/18CitrullinationIndexing code24
- G01N 2440/20Formation of disulphide bridgesIndexing code9
- G01N 2440/30SulphationIndexing code6
All 16 subgroupsShow fewer
- G01N 2440/32BiotinylationIndexing code6
- G01N 2440/16AmidationIndexing code4
- G01N 2440/26NitrosylationIndexing code3
- G01N 2440/28PegylationIndexing code3
- G01N 2440/40Addition of nucleotides or derivativesIndexing code3
- G01N 2440/24HydroxylationIndexing code1
- G01N 2440/34Addition of amino acidIndexing code1
- G01N 2440/22IodinationIndexing code0
Recent patents
- Target-based method for high-throughput and subclass specific IgG glycan profiling in human plasma15 Sep 2026US 12,736,541 B2Regeneron Pharmaceuticals, Inc.
- Method and kit for determining benefit of chemotherapy8 Sep 2026US 12,729,405 B2St. Jude Children?S Research Hospital
- Diagnostic method based on large scale identification of post-translational modification of proteins18 Aug 2026US RE50,997 E1President and Fellows of Harvard College
- Biochemical medical diagnostic kit21 Jul 2026US 12,687,547 B2
- PLK1 target phosphorylation status and treatment of cancer with PLK1 inhibitors16 Jun 2026US 12,655,462 B2Cardiff Oncology, Inc.
- Compositions and methods for detection of aberrant cdk5 expression8 Oct 2026US 2026/0309712 A1Arizona Board of Regents on Behalf of the University of Arizona
- Combination therapy of polio virus receptor inhibitors and fucose8 Oct 2026US 2026/0309713 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Plk1 target phosphorylation status and treatment of cancer with plk1 inhibitors1 Oct 2026US 2026/0297646 A1Cardiff Oncology, Inc.
- Method for the in vitro diagnosis of a neurodegenerative disease1 Oct 2026US 2026/0298947 A1Institut National de la Sante et de la Recherche Medicale
- Compositions, methods and kits for profiling protein modifications10 Sep 2026US 2026/0266827 A1Purdue Research Foundation
Most cited
By later US patents
- Methods of cell culture59US 9,217,168 B2Momenta Pharmaceuticals, Inc. · 2015
- Methods of cell culture51US 9,663,810 B2Momenta Pharmaceuticals, Inc. · 2017
- DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia35US 7,442,685 B2The University of North Carolina at Chapel Hill · 2008
- Methods and compositions for detecting the activation state of multiple proteins in single cells33US 7,563,584 B2The Board of Trustees of the Leland Stanford Junior University · 2009
- Methods of cell culture30US 10,144,944 B2Momenta Pharmaceuticals, Inc. · 2018